The global topical drug delivery market was valued at USD 208.3 billion in 2023 and expected to reach USD 498.62 billion by 2033 at a CAGR of 9.12%.
The global topical drug delivery market has experienced steady growth from the past few years and anticipated to witness impressive opportunities in the coming years as well. This is owing to the growing research and development in topical drug delivery and use of topical drugs coupled with nanotechnology to enhance skin absorption. A topical drug is a drug that is applied to a specific place on or in the body. Generally topical administration of drugs refers to the application of the drug to body surfaces such as mucous membrane or skin to treat diseases. The drugs administered through skin or mucous membrane get in to the skin more deeply and better retained, allowing more effective results. The other benefits of Topical drugs include sustained release, and lessening of in oscillations in plasma medicine proportion. Topical drugs are available in a wide range of classes including creams, foams, lotions, gels, and ointments. Topical drugs are applicable in skin infections, burns. They are used as sunscreen lotions, and for treatment of corn, warts, and skin irritations. Topical drugs can also be inhalational for e.g. inhalational drugs used to treat asthma patients. Topical drugs also include eye drops or ear drops for e.g. eye drops used to treat conjunctivitis or ear drop used to treat ear infection.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global topical drug delivery. The historic years considered for the study are 2018-2021, the base year is 2022, the estimated year is 2023, and forecast period is 2023-2033.
The global topical drug delivery market is expected to witness sustainable growth rate during the forecast period. Rising skin ailments, increasing cases of burn injuries, and rising frequency of eye or ear infections are the major factors for the market growth.
Also, growing number of asthma patients and increasing prevalence of diabetes mostly amongst the geriatric population has further enhanced the growth of the overall market across the globe.
However, increase in side effects of medicines like irritations coupled with the product recalls acts as a restraint to the market growth.
The topical drug delivery market is classified into product, route of administration, facility of use, and region.
Based on product, the market is segmented into solid formulations, liquid formulations, semi-solid formulation and transdermal products. The semi-solid formulation segment accounted for the largest market share in 2023. This is attributed to its features such as broad applications of topical pastes and higher accessibility of topical gels, worldwide.
Based on route of administration the market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery. Based on facility of use, the market is segmented into hospitals & clinics, burn centres, homecare settings, other facilities such as academic & research institutes and diagnostic centres.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
The North America region contributed to major market share in the market and expected to continue the dominance during the forecast period. the growth in the region owes to the growing prevalence of skin diseases, increasing funding in research and development, increasing government aids, introduction and approval to new innovative formulations in drug delivery.
The key manufacturers involved in the global topical drug delivery market include Bayer AG (Germany), Cipla Ltd (India), GlaxoSmithKline (UK), Glenmark Pharmaceuticals (India), Johnson & Johnson (US), Novartis AG (Switzerland), Nestle SA (Switzerland), Crescita Therapeutics Inc. (Canada) Bausch Health Companies (Canada), Hisamitsu Pharmaceutical (Japan), Mylan (US), and Crescita Therapeutics Inc. (Canada).
• What are the key trends in the market?
• How the market (and its various sub segments) has grown in last four years and what would be the growth rate in next five years?
• What are the key strategies adopted by the major vendors to lead in the market?
• What is the market share of the top players?
The research study extensively uses both secondary and primary research methodologies. More than 200 industry leaders from various phases of the value chain (demand side, supply side, resellers/distributors, and other independent consultants) were interviewed to gain crucial insights about this market and validate the research findings. Secondary sources referred for the research study include company websites, annual reports, paid database tools, investor presentations, webinars, blogs, news/journals, whitepapers, survey papers, associations, and government websites. All the collected data and insights were then processed using our proprietary data mining software that executes various algorithms to make projections for the forecast period.
Topical Drug Delivery Market Scope:
Report Data | Topical Drug Delivery Market |
Topical Drug Delivery Market Forecast Value 2033 | 498.62Billion |
Topical Drug Delivery Market CAGR 2023 - 2033 | 9.12% |
Topical Drug Delivery Market Forecast Period | 2023 - 2033 |
Topical Drug Delivery Market Base Year | 2022 |
Regional Scope | North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Key Companies Profiled | Bayer AG (Germany), Cipla Ltd (India), GlaxoSmithKline (UK), Glenmark Pharmaceuticals (India), Johnson & Johnson (US), Novartis AG (Switzerland), Nestle SA (Switzerland), Crescita Therapeutics Inc. (Canada) Bausch Health Companies (Canada), Hisamitsu Pharmaceutical (Japan), Mylan (US), and Crescita Therapeutics Inc. (Canada). |
Key Segments | By Product By Route of Administration By Facility of Use By Region |
Report Coverage | Market Sizing, Market Forecasting, Market Dynamics, Market Trends, Market Development Analysis, Market Share Analysis, Regional Analysis, Competitive Positioning, Competitive Benchmarking, Competitive Landscape, Company Profiling, Regulation Analysis, etc. |
Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
Segmentation on the basis of any specific country or region
Any segment can be classified on the basis of application
Application segment can be further divided on the basis of companies
The companies profiled are not limited, we can incorporate additional companies of your choice
We can split the company market share on the basis of product, application and region
Report can be prepared for any specific country/region/segment
Customers can be added on the basis of regions and countries
We manage our resources 24/7 to identify issues and address them before they become problems
We are committed to providing reliable and highly accurate data with an excellent quality control system
6 Major regions and 40+ countries level analysis accomplished
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Reports Published Per Year
Consulting Projects till date
Fortune 500 Clients
Analysts and Contract Consultants